Extracorporeal Membrane Oxygenation Market Scope And Analysis

Report Code : TIPHE100001219
Category : Life Sciences

No. of Pages : 150

Buy Now

Extracorporeal Membrane Oxygenation Market Scope and Analysis by 2028

Buy Now

Extracorporeal Membrane Oxygenation Market Report Scope

Report Attribute	Details
Market size in 2023	US$ 0.58 Billion
Market Size by 2031	US$ 0.74 Billion
Global CAGR (2023 - 2031)	3.10%
Historical Data	2021-2022
Forecast period	2024-2031
Segments Covered	By Modality Venoarterial extracorporeal membrane oxygenation Venovenous extracorporeal membrane oxygenation Arteriovenous extracorporeal membrane oxygenation By Application Respiratory and Cardiology By Age Group Adults Pediatrics Neonates
Regions and Countries Covered	North America US Canada Mexico Europe UK Germany France Russia Italy Rest of Europe Asia-Pacific China India Japan Australia Rest of Asia-Pacific South and Central America Brazil Argentina Rest of South and Central America Middle East and Africa South Africa Saudi Arabia UAE Rest of Middle East and Africa
Market leaders and key company profiles	Terumo Group Medtronic Plc MicroPort Scientific Corporation LivaNova Plc Nipro Medical Corporation Eurosets S R L Getinge AB Braile Biomedica Fresenius Medical Care AG Co KGaA

Extracorporeal Membrane Oxygenation Market News and Recent Developments

The extracorporeal membrane oxygenation market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the extracorporeal membrane oxygenation market are listed below:

LivaNova P.L.C., a market-leading medical technology and innovation company, announced it received 510(k) clearance for extracorporeal membrane oxygenation (ECMO) from the US Food and Drug Administration (FDA) for LifeSPARC, the Company’s next-generation Advanced Circulatory Support (ACS) pump and controller system. LivaNova leveraged existing real-world evidence inclusive of data collected during the COVID-19 pandemic to receive this new indication. (Source: LivaNova PLC, Press Release, November 2022)
Inspira Technologies OXY BHN Ltd. introduces the "Liby™" System, an advanced form of life support better known by the medical industry as extracorporeal membrane oxygenation (ECMO), used to treat patients with life-threatening heart and lung failure. (Source: Inspira Technologies, Press Release, July 2022)

Extracorporeal Membrane Oxygenation Market Report Coverage and Deliverables

The “Extracorporeal Membrane Oxygenation Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:

Extracorporeal membrane oxygenation market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
Extracorporeal membrane oxygenation market trends as well as market dynamics such as drivers, restraints, and key opportunities
Detailed PEST/Porter’s Five Forces and SWOT analysis
Extracorporeal membrane oxygenation market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments.
Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the extracorporeal membrane oxygenation market
Detailed company profiles